RJFSA
ICVX

Raymond James Financial Services Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,361
Closed -$103K – 3371
2023
Q2 		$103K Buy
+10,361
New +$82.9K ﹤0.01% 3055

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Raymond James Financial Services Advisors's ICVX Position: Q3 2023 in Review

Raymond James Financial Services Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q3 2023, closing a stake of 10,361 shares — an estimated $103K sold.

Raymond James Financial Services Advisors first reported a position in ICVX in Q2 2023 and held it in 1 quarter. The position peaked at $103K in Q2 2023. 64 funds tracked by Wall St. Rank hold ICVX as of Q3 2023.

  • Raymond James Financial Services Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 10,361 Icosavax, Inc. Common Stock shares in Q3 2023, an estimated $103K.
  • Raymond James Financial Services Advisors first reported a position in Icosavax, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's Icosavax, Inc. Common Stock position peaked at $103K in Q2 2023.
  • 64 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q3 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.